Finding better ways to provide the materials the world needs
Our business
We operate in 35 countries where our 57,000 employees are working to find better ways to provide the materials the world needs
Our purpose in action
Continuous improvement and innovation are part of our DNA
Innovation
The need for innovation is greater than ever
We supply the metals and minerals used to help the world grow and decarbonise
Iron Ore
The primary raw material used to make steel, which is strong, long-lasting and cost-efficient
Lithium
The lightest of all metals, it is a key element needed for low-carbon technologies
Copper
Tough but malleable, corrosion-resistant and recyclable, and an excellent conductor of heat and transmitter of electricity
Bringing to market materials critical to urbanisation and the transition to a low-carbon economy
Oyu Tolgoi
One of the most modern, safe and sustainable operations in the world
Rincon Project
A long-life, low-cost and low-carbon lithium source
Simandou Project
The world’s largest untapped high-grade iron ore deposit
Providing materials the world needs in a responsible way
Climate Change
We’re targeting net zero emissions by 2050
Nature solutions
Our nature-based solutions projects complement the work we're doing to reduce our Scope 1 and 2 emissions
Decarbonisation progress update
We have a clear plan on decarbonisation - find out more about our progress in 2024
We aim to deliver superior returns to our shareholders while safeguarding the environment and meeting our obligations to wider society
Investor seminars
Our Investor seminar will be held in London on 4 December, and our Decarbonisation update on 5 December
Get the latest news, stories and updates
Things you can't live without
Our podcast discussing what needs to happen to create a sustainable future for the everyday items we have come to rely on
The 'f' word of innovation
How unlocking innovation requires a change of mindset
Reducing titanium oxide's carbon footprint
Our BlueSmelting technology could drastically reduce carbon emissions during ore processing
Discover more about life at Rio Tinto
Graduates and students
If you want to drive real change, we have just the place to do it
Empowering families with flexibility
Supporting new parents of any gender with equal access to parental leave
Available jobs
Join our team
MONTREAL, Canada - Antimicrobial resistance (AMR) is a looming health crisis that, according to the World Heath Organization, if left unchecked, could become a global scale threat to human life and prosperity. Thanks to a C$500,000 gift from Rio Tinto to the McGill Antimicrobial Resistance Centre, made through the Rio Tinto Aluminium Canada Fund, new innovations in the fight against resistant bacteria will be developed in Montreal.AMR occurs when bacteria and other microbes become resistant to antibiotics, disinfectants and other antimicrobial products. The consequences could be devastating: without reliable antibiotics, even the simplest of surgeries could pose risk of major infections. Similarly, hallmarks of modern medicine such as chemotherapy, transplantation and joint replacements — all of which require antibiotics — could come with much more risk in the not-so-distant future.Antimicrobial Resistance Centre Director, Dr. Dao Nguyen, said: “No new antibiotics have been developed since the 1990s, and the discovery pipeline is dry. If we don’t act now, we could be living in a post-antibiotic world. At the AMR Centre, we will be able to explore innovative new ways to prevent and treat resistant infections.”Not only have no new antibiotics been developed in over 20 years, but the ones we have are rapidly becoming ineffective as antibiotic resistant bacteria evolve. To help scientists at the Research Institute of the McGill University Health Centre and McGill University find innovative ways to curb infection, Rio Tinto’s gift will create the Antimicrobial Resistance Discovery Incubator. This research accelerator will award seed funding to test promising ideas that could lead to new antibiotics or other ways to fight antimicrobial resistant super bugs.Rio Tinto Aluminium Chief Executive Ivan Vella said: “Antimicrobial resistance is a global issue and, as a global company, Rio Tinto is pleased to support research that will have a positive impact on people’s health worldwide. We are fortunate to have some of the leading researchers in infection and immunity here in Montreal. We are confident that the new Antimicrobial Discovery Incubator will lead to lifesaving discoveries, and we are proud to play a part in finding innovative solutions.”Most of the antibiotics we have today were found in nature—penicillin, for instance, is a type of mould. To encourage pharmaceutical companies to develop new antibiotics, Rio Tinto’s gift will support researchers searching for the next penicillin, as well as new innovations that will help prevent or curb the rise in drug resistant bacteria.MUHC Foundation Dream Big. Solve Humanity’s Deadliest Puzzles campaign (MI4) Co-Chair, Heather Munroe-Blum, said: “Antibiotics are the cornerstone of modern medicine. The advancements we have made in surgery, chemotherapy and more are under threat unless we find new ways to treat infections. We do that by investing in life-changing research by some of the smartest minds at the RI-MUHC and McGill.”MUHC Foundation Dream Big. Solve Humanity’s Deadliest Puzzles campaign (MI4) Co-Chair, Mark Smith, said: “Antibiotic resistance could dial medicine back a century. We cannot stand by and let this happen. The impact of Rio Tinto’s gift to the new Antimicrobial Resistance Discovery Incubator has the potential to reverberate around the globe.”The McGill Antimicrobial Resistance Centre is part of the McGill Interdisciplinary Initiative in Infection and Immunity (MI4), which brings together over 250 experts from a wide range of fields to tackle the global threat of infectious diseases. MI4 is leading research to stop diseases like tuberculosis, Hepatitis C, COVID-19 and more from taking lives.MUHC Foundation Dream Big Campaign Co-Chair Suzanne Legge Orr said: “My fellow co-chairs, Marc Parent, Jean Charest and I wish to thank Rio Tinto for this extraordinary, forward-thinking gift. The COVID-19 pandemic has shown us the vast impact infectious diseases can have on our world. With the help of this gift, MI4 and the AMR Centre will safeguard us against a post-antibiotic world.”The new Antimicrobial Resistance Discovery Incubator will give out its first seed funding awards next year.MUHC Foundation President and CEO Julie Quenneville said: “We are proud to partner with Rio Tinto to support innovation in antibiotic discovery. The new incubator will bring forward ideas that will revolutionize how we prevent and treat infections. The discovery of penicillin changed the world; I am confident that MI4 will change it again with the discoveries of the AMR Centre.”McGill University Interdisciplinary Initiative in Infection and Immunity (MI4) Director, Dr. Marcel Behr, said: “MI4 would like to thank Rio Tinto for their generous gift and contribution to MI4’s future successes. With Rio Tinto’s donation supporting the leadership of the AMR Centre, we will be able to roll up our sleeves, and gather interdisciplinary teams to find solutions.”About the McGill University Health Centre FoundationThe McGill University Health Centre (MUHC) Foundation raises funds to support excellence in patient care, research and teaching at the McGill University Health Centre, one of the top university hospitals in Canada. Our Dream Big Campaign to change the course of lives and medicine is raising millions of dollars to solve humanity’s deadliest puzzles: infectious diseases; end cancer as a life-threatening illness; fix broken hearts through innovative cardiac care; detect the silent killers—ovarian and endometrial cancers—early; create the best skilled health care teams in Canada; and much more. We are rallying our entire community to solve the world’s most complex health care challenges.About the RI-MUHCThe Research Institute of the McGill University Health Centre (RI-MUHC) is a world-renowned biomedical and healthcare research centre. The institute, which is affiliated with the Faculty of Medicine of McGill University, is the research arm of the McGill University Health Centre (MUHC) – an academic health centre located in Montreal, Canada, that has a mandate to focus on complex care within its community. The RI-MUHC supports over 450 researchers and around 1,200 research trainees devoted to a broad spectrum of fundamental, clinical and health outcomes research at the Glen and the Montreal General Hospital sites of the MUHC. Its research facilities offer a dynamic multidisciplinary environment that fosters collaboration and leverages discovery aimed at improving the health of individual patients across their lifespan. The RI-MUHC is supported in part by the Fonds de recherche du Québec – Santé (FRQS). rimuhc.caAbout MI4The McGill Interdisciplinary Initiative in Infection and Immunity (MI4), brings together a group of more than 200 scientists and researchers, with the goal of developing new solutions for microbial threats and delivering these solutions to the patients and populations who need them most.
ContactsRio TintoSimon LetendreM +1514796 4973simon.letendre@riotinto.comMcGill University Health Centre FoundationTarah Schwartztarah.schwartz@muhc.mcgill.caKelly Albertkelly.albert@muhc.mcgill.ca
Category: Canada
How we process personal data provided or obtained through this website.
With the exception of the use of cookies, Rio Tinto generally does not seek to collect personal data through this website. However if you choose to provide personal data to Rio Tinto through this website (for example, by sending us an email), we will process that personal data to answer your query and if relevant, to manage our business relationship with you or your company. We won't process that personal data for other purposes except where required to meet our legal obligations or otherwise as authorised by law and notified to you.
If you choose to subscribe to our media releases or other communications, you can unsubscribe at any time (by following the instructions in the email or by contacting us).
With your consent, our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. A cookie is a small file of letters and numbers that we store on your browser or the hard drive of your computer if you agree. Cookies contain information that is transferred to your computer's hard drive.
As some data privacy laws regulate IP addresses and other information collected through the use of cookies as personal data, Rio Tinto’s processing of such personal data needs to comply with its Data Privacy Standard (see Part 1 of our Privacy Policy), and also applicable data privacy laws.
With the exception of the use of cookies (explained below), Rio Tinto generally does not seek to collect personal data through this website. However if you choose to provide personal data to Rio Tinto through this website (for example, by sending us an email), we will process that personal data to answer your query and if relevant, to manage our business relationship with you or your company. We won't process that personal data for other purposes except where required to meet our legal obligations or otherwise as authorised by law and notified to you.
Part 1 of this Privacy Policy contains the Rio Tinto Data Privacy Standard, which provides an overview of Rio Tinto’s approach to personal data processing. There is additional information in the appendices to the Data Privacy Standard, including information about disclosures, trans-border data transfers, the exercise of data subject rights and how to make complaints or obtain further information relating to Rio Tinto’s processing of your personal data.
If you choose to subscribe to our media releases or other communications, you can unsubscribe at any time (by following the instructions in the email or by contacting us at digital.comms@riotinto.com).
With your consent, our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site.
A cookie is a small file of letters and numbers that we store on your browser or the hard drive of your computer if you agree. Cookies contain information that is transferred to your computer's hard drive.
As some data privacy laws regulate IP addresses and other information collected through the use of cookies as personal data, Rio Tinto’s processing of such personal data needs to comply with its Data Privacy Standard (see Part 1 of this Privacy Policy), and also applicable data privacy laws.
These Cookies are used to provide a better user experience on the site, such as by measuring interactions with particular content or remembering your settings such as language or video playback preferences.
These Cookies allow us to analyse site usage in order to evaluate and improve its performance. They help us know how often you come to our site and when, how long you stay and any performance issues you experience whilst you are on our site.
These Cookies are used by advertising companies to inform and serve personalised ads to your devices based on your interests. These Cookies also facilitate sharing information with social networks or recording your interactions with particular ads.